{"id":"https://openalex.org/W7204683676","doi":"https://doi.org/10.1080/03007995.2026.2722697","title":"Real-world adherence and healthcare resource utilization following transition to aripiprazole once-every-2-months from oral or once-monthly aripiprazole among patients diagnosed with schizophrenia in the United States","display_name":"Real-world adherence and healthcare resource utilization following transition to aripiprazole once-every-2-months from oral or once-monthly aripiprazole among patients diagnosed with schizophrenia in the United States","publication_year":2026,"publication_date":"2026-07-03","ids":{"openalex":"https://openalex.org/W7204683676","doi":"https://doi.org/10.1080/03007995.2026.2722697","pmid":"https://pubmed.ncbi.nlm.nih.gov/42669177"},"language":"en","primary_location":{"id":"doi:10.1080/03007995.2026.2722697","doi":"https://doi.org/10.1080/03007995.2026.2722697","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2026.2722697","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2026.2722697?needAccess=true","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7204683676"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2026.2722697?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022244026","display_name":"Kristine Harrsen","orcid":"https://orcid.org/0009-0008-8906-070X","observed_orcids":["https://orcid.org/0009-0008-8906-070X"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Kristine Harrsen","raw_affiliation_strings":["H. Lundbeck A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103139751","display_name":"Murat Yildirim","orcid":"https://orcid.org/0000-0001-6192-1047","observed_orcids":["https://orcid.org/0000-0001-6192-1047"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"Murat Yildirim","raw_affiliation_strings":["H. Lundbeck A/S"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S","institution_ids":["https://openalex.org/I133593841"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092729210","display_name":"Clodagh Beckham","orcid":"https://orcid.org/0009-0003-2351-2519","observed_orcids":["https://orcid.org/0009-0003-2351-2519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clodagh Beckham","raw_affiliation_strings":["Otsuka Pharmaceutical Europe Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Europe Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030703034","display_name":"Karimah S. Bell Lynum","orcid":"https://orcid.org/0000-0002-2045-9578","observed_orcids":["https://orcid.org/0000-0002-2045-9578"]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karimah S. Bell Lynum","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5135983303","display_name":"Norman Atkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norman Atkins","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148734124","display_name":"Onur Baser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I174216632","display_name":"City University of New York","ror":"https://ror.org/00453a208","country_code":"US","type":"education","lineage":["https://openalex.org/I174216632"]},{"id":"https://openalex.org/I4405392","display_name":"Bo\u011fazi\u00e7i University","ror":"https://ror.org/03z9tma90","country_code":"TR","type":"education","lineage":["https://openalex.org/I4405392"]}],"countries":["TR","US"],"is_corresponding":false,"raw_author_name":"Onur Baser","raw_affiliation_strings":["Columbia Data Analytics","Department of Economics, Bo\u011fazi\u00e7i University","Graduate School of Public Health, City University of New York (CUNY)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia Data Analytics","institution_ids":[]},{"raw_affiliation_string":"Department of Economics, Bo\u011fazi\u00e7i University","institution_ids":["https://openalex.org/I4405392"]},{"raw_affiliation_string":"Graduate School of Public Health, City University of New York (CUNY)","institution_ids":["https://openalex.org/I174216632"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093535666","display_name":"Katarzyna Rodchenko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katarzyna Rodchenko","raw_affiliation_strings":["Columbia Data Analytics"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia Data Analytics","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033579405","display_name":"Annette Urganus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annette Urganus","raw_affiliation_strings":["Lundbeck LLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck LLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118994381","display_name":"Shivanshu Awasthi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivanshu Awasthi","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc","institution_ids":["https://openalex.org/I4405268153"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110212621","display_name":"Soma S. Nag","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Soma S. Nag","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization Inc","institution_ids":["https://openalex.org/I4405268153"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5103139751"],"corresponding_institution_ids":["https://openalex.org/I133593841"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"7","first_page":"1459","last_page":"1472"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6845999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6845999956130981,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.29100000858306885,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9449999928474426},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7879999876022339},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.675000011920929},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9169999957084656},{"id":"https://openalex.org/keywords/proportion-of-days-covered","display_name":"proportion of days covered","score":0.6809999942779541},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.9769999980926514},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.9520000219345093},{"id":"https://openalex.org/keywords/outpatient-visits","display_name":"outpatient visits","score":0.8859999775886536},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.6019999980926514},{"id":"https://openalex.org/keywords/kythera","display_name":"Kythera","score":0.49399998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9463000297546387},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.8842999935150146},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6901000142097473},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5273000001907349},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4641999900341034},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.35600000619888306},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3384000062942505},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.33660000562667847},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.2955999970436096},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.28700000047683716},{"id":"https://openalex.org/C3019806175","wikidata":"https://www.wikidata.org/wiki/Q11974939","display_name":"Health professionals","level":3,"score":0.28519999980926514},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C2992695702","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental healthcare","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.2581999897956848},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.25769999623298645},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2554999887943268},{"id":"https://openalex.org/C134362201","wikidata":"https://www.wikidata.org/wiki/Q317309","display_name":"Mental health","level":2,"score":0.2551000118255615},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.25459998846054077}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006295","descriptor_name":"Health Resources","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/03007995.2026.2722697","doi":"https://doi.org/10.1080/03007995.2026.2722697","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2026.2722697","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2026.2722697?needAccess=true","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:42669177","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42669177","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/03007995.2026.2722697","doi":"https://doi.org/10.1080/03007995.2026.2722697","is_oa":true,"landing_page_url":"https://doi.org/10.1080/03007995.2026.2722697","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/03007995.2026.2722697?needAccess=true","source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320333791","display_name":"Otsuka Pharmaceutical Development and Commercialization","ror":"https://ror.org/001nxvg84"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204683676.pdf","grobid_xml":"https://content.openalex.org/works/W7204683676.grobid-xml"},"referenced_works_count":67,"referenced_works":["https://openalex.org/W1151536748","https://openalex.org/W1807043087","https://openalex.org/W1979728316","https://openalex.org/W1989794259","https://openalex.org/W2003289380","https://openalex.org/W2037650878","https://openalex.org/W2042353763","https://openalex.org/W2044417549","https://openalex.org/W2047489249","https://openalex.org/W2050187883","https://openalex.org/W2057464084","https://openalex.org/W2057780602","https://openalex.org/W2075029547","https://openalex.org/W2082474120","https://openalex.org/W2092192575","https://openalex.org/W2104819369","https://openalex.org/W2110548428","https://openalex.org/W2139645720","https://openalex.org/W2140452679","https://openalex.org/W2187017043","https://openalex.org/W2888733935","https://openalex.org/W2891998787","https://openalex.org/W2892796001","https://openalex.org/W2976781573","https://openalex.org/W3013166411","https://openalex.org/W3039300106","https://openalex.org/W3092607921","https://openalex.org/W3097039163","https://openalex.org/W3118412786","https://openalex.org/W3124121244","https://openalex.org/W3134421607","https://openalex.org/W3154038235","https://openalex.org/W3158476454","https://openalex.org/W3164484979","https://openalex.org/W3176018002","https://openalex.org/W4205208574","https://openalex.org/W4210542055","https://openalex.org/W4210725547","https://openalex.org/W4211025465","https://openalex.org/W4214772835","https://openalex.org/W4223619012","https://openalex.org/W4229038037","https://openalex.org/W4234860686","https://openalex.org/W4252215407","https://openalex.org/W4281687410","https://openalex.org/W4320040093","https://openalex.org/W4323361057","https://openalex.org/W4323572410","https://openalex.org/W4360807802","https://openalex.org/W4384067619","https://openalex.org/W4385307960","https://openalex.org/W4386368685","https://openalex.org/W4386465656","https://openalex.org/W4399189981","https://openalex.org/W4401816853","https://openalex.org/W4402434458","https://openalex.org/W4409317997","https://openalex.org/W4409542193","https://openalex.org/W4409947683","https://openalex.org/W4412473061","https://openalex.org/W4412489443","https://openalex.org/W4414752783","https://openalex.org/W4416466577","https://openalex.org/W4417264604","https://openalex.org/W7128800268","https://openalex.org/W7129010507","https://openalex.org/W7138956647"],"related_works":["https://openalex.org/W7211952887","https://openalex.org/W4309164340","https://openalex.org/W2794938346","https://openalex.org/W4393166458","https://openalex.org/W2892043316","https://openalex.org/W2887988025","https://openalex.org/W3121942877","https://openalex.org/W4407386714","https://openalex.org/W4385577721","https://openalex.org/W2991428633"],"abstract_inverted_index":{"Objective":[0],"To":[1],"assess":[2],"adherence":[3,236],"and":[4,77,85,88,110,129,141,161,189,194,197,237],"healthcare":[5],"resource":[6],"utilization":[7],"(HCRU)":[8],"among":[9],"adults":[10],"diagnosed":[11,245],"with":[12,165,233,246],"schizophrenia":[13],"who":[14,34],"transitioned":[15,35],"from":[16,42,66,183],"oral":[17,67],"aripiprazole":[18,20,25,68],"or":[19],"monohydrate":[21,26],"once-monthly":[22],"(AOM)":[23],"to":[24,36,228],"2-month":[27],"ready-to-use":[28],"(Ari":[29],"2MRTU).Methods":[30],"Data":[31],"for":[32],"patients":[33,92,164,201,244],"Ari":[37,59,229],"2MRTU":[38,60,230],"were":[39,51,116,176],"retrospectively":[40],"obtained":[41],"the":[43],"Kythera":[44],"Labs":[45],"United":[46],"States":[47],"closed-claims":[48],"database.":[49],"Outcomes":[50],"examined":[52],"6":[53],"months":[54],"pre-":[55],"versus":[56,119,179,214],"post-index":[57],"(first":[58],"claim":[61],"=":[62,70,139,143,159,174,186,225],"index).Results":[63],"Following":[64,181],"transition":[65,182],"(n":[69,185],"153),":[71],"proportion":[72,89,162,198],"of":[73,90,113,163,199],"days":[74],"covered":[75],"(PDC)":[76],"medication":[78],"possession":[79],"ratio":[80],"(MPR)":[81],"increased":[82,96,191,202],"by":[83,97,192,203],"21.3%":[84],"24.6%,":[86],"respectively,":[87,196],"adherent":[91,200],"(MPR":[93],"\u2265":[94,166],"0.8)":[95],"59.2%":[98],"(all":[99,205],"p":[100,138,142,158,173,206,224],"<":[101,207],"0.001).":[102,208],"Mean":[103],"\u00b1":[104,122,126,131,135,152,156,217,221],"standard":[105],"deviation":[106],"all-cause":[107],"inpatient":[108],"visits":[109,128],"hospital":[111],"length":[112],"stay":[114],"(LOS)":[115],"lower":[117,177,212],"post-":[118,178,213],"pre-index":[120],"(0.28":[121],"0.88":[123],"vs":[124,133,154,171,219],"0.67":[125],"1.85":[127],"1.05":[130,153,220],"3.95":[132],"2.63":[134,218],"6.14":[136],"days,":[137,223],"0.019":[140],"0.008,":[144],"respectively).":[145],"For":[146],"schizophrenia-related":[147],"HCRU,":[148],"mean":[149],"LOS":[150,210],"(0.19":[151],"0.91":[155],"3.94,":[157],"0.031)":[160],"1":[167],"outpatient":[168],"visit":[169],"(36.0%":[170],"54.9%,":[172],"0.019)":[175],"pre-index.":[180],"AOM":[184],"526),":[187],"PDC":[188],"MPR":[190],"38.8%":[193],"36.6%,":[195],"47.9%":[204],"All-cause":[209],"was":[211,231],"pre-transition":[215],"(0.64":[216],"3.93":[222],"0.047).Conclusion":[226],"Transitioning":[227],"associated":[232],"significantly":[234],"improved":[235],"reductions":[238],"in":[239,243],"certain":[240],"HCRU":[241],"measures":[242],"schizophrenia.":[247]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-08-31T00:00:00"}